abstract |
Disclosed in the present invention is a compound as represented by formula (A), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a solvate thereof. The new compound as represented by formula (A) disclosed in the present invention exhibits good URAT1 inhibitory activities, providing a new medicinal possibility for the clinical treatment of diseases associated with abnormal URAT1 activities. |